In celebration of its 350 years of existence, Merk is offering a series of grants to stimulate innovative research in challenging areas of future importance. Merck intends to provide several research grants of up to EUR 350,000 per year for 3 years in various research areas with the option of extension or expansion.
About the Grant Provider
The Merck Group, branded and commonly known as Merck, is a German multinational chemical, pharmaceutical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.
Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.
Fill out the Application Form with your research proposal, use only non-confidential information by August, 15th, 2018. Please make sure you have read and accepted the terms and conditions before you submit the application form.
All selected applicants will be invited to a three day workshop after signature of a confidential disclosure and workshop participation agreement to discuss and optimize a more detailed confidential research proposal further together with Merck scientists.
At the end of the workshop participants will present their optimized research proposal and the winning applicants will be selected by Merck. Merck will then enter into bilateral collaboration agreements with the winning recipients to enable pay-out of the research grant and project start in 2019.
August 15, 2018